Motofen is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Sebela Pharmaceuticals Inc.. The primary component is Atropine Sulfate; Difenoxin Hydrochloride.
Product ID | 54766-200_7cfe62d8-961c-5023-e053-2a91aa0a3575 |
NDC | 54766-200 |
Product Type | Human Prescription Drug |
Proprietary Name | Motofen |
Generic Name | Difenoxin And Atropine Sulfate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-04-11 |
Marketing Category | NDA / NDA |
Application Number | NDA017744 |
Labeler Name | Sebela Pharmaceuticals Inc. |
Substance Name | ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE |
Active Ingredient Strength | 0 mg/1; mg/1 |
Pharm Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Antidiarrheal [EPC] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-04-11 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | NDA |
Application Number | NDA017744 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-04-11 |
Marketing Category | NDA |
Application Number | NDA017744 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-04-11 |
Ingredient | Strength |
---|---|
ATROPINE SULFATE | .025 mg/1 |
SPL SET ID: | 4cd3f029-a5e3-5812-e054-00144ff8d46c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MOTOFEN 81023107 1023107 Dead/Cancelled |
Johnson & Johnson 0000-00-00 |
MOTOFEN 73765421 1552470 Live/Registered |
CARNRICK LABORATORIES, INC. 1988-11-23 |